Speaker

Julie Mori

PhD

hVivo

Session(s)

Safety and Efficacy of Oral RV521 in a Human Respiratory Syncytial Virus (RSV) Phase 2a Ch...
Monday, May 21 11:00 AM - 11:15 AM